meglumine has been researched along with meglumine cyclic adenylate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, DH; Jia, L | 1 |
| Wang, W; Wu, D; Xu, R; Yang, Y; Zhao, Y | 1 |
| Guo, L; Li, W; Liao, J; Lin, D; Lu, N; Pu, B; Song, Y; Xie, J; Yang, Y; Yang, Z; Zhang, Y | 1 |
| Chen, JL; Liu, H; Liu, W; Yan, H | 1 |
4 other study(ies) available for meglumine and meglumine cyclic adenylate
| Article | Year |
|---|---|
[Negative chronotropic effects of meglumine cyclic adenylate on heart].
Topics: Action Potentials; Animals; Cyclic AMP; Depression, Chemical; Female; Guinea Pigs; Heart Rate; Male; Meglumine; Mice; Rabbits; Rats; Sinoatrial Node; Sorbitol; Vasodilator Agents | 1988 |
[A multicenter clinical study on clinical effects of meglumine cyclic adenylate in treating patients with chronic pulmonary heart disease].
Topics: Aged; Aged, 80 and over; Chronic Disease; Cyclic AMP; Female; Humans; Male; Meglumine; Middle Aged; Multicenter Studies as Topic; Pulmonary Heart Disease | 2001 |
Meglumine cyclic adenylate improves neurological function following acute spinal cord injury in rats.
Topics: Adenylyl Cyclases; Animals; Behavior, Animal; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Female; Immunohistochemistry; Male; Meglumine; Methylprednisolone; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Injuries | 2014 |
Effects of meglumine cyclic adenylate pretreatment on systemic inflammatory response syndrome induced by lipopolysaccharide in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cyclic AMP; Injections, Intravenous; Interleukin-1; Interleukin-10; Interleukin-6; Lipopolysaccharides; Male; Meglumine; Rats; Rats, Sprague-Dawley; Systemic Inflammatory Response Syndrome; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2017 |